What is the Current Share Price of Beta Drugs Ltd?
- Answer Field
-
Beta Drugs Ltd share price is for NSE ₹ 1,350.70 & for BSE ₹ 0.00 as on May 22 2026 03:29 PM.
As of the latest trading session, BETA DRUGS LIMITED is trading at ₹1350.7, up by ₹113.60 or 9.18% from its previous close. The stock has moved between ₹1230.00 and ₹1420.00 today. Over the past year, the stock has delivered a return of -22.21%. In the last month, it has returned 4.00%.
| Particulars | MAR 2026 (Values in Cr) |
|---|---|
| Revenue | 54.35 |
| Operating Expense | 50.19 |
| Net Profit | 5.33 |
| Net Profit Margin (%) | 9.80 |
| Earnings Per Share (EPS) | 5.26 |
| EBITDA | 12.67 |
| Effective Tax Rate (%) | 24.50 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENT L | 33.07 | 13.67 | 1.60 | 253.43 | 23.12 | 40.00 |
| BLISS GVS PHARMA LTD. | 300.20 | 24.29 | 2.66 | 3175.78 | 118.35 | 304.30 |
| CIPLA LTD | 1398.95 | 27.70 | 3.28 | 113007.26 | 1165.55 | 1672.20 |
| FERMENTA BIOTECH LTD. | 302.65 | 10.07 | 2.27 | 890.73 | 256.40 | 399.00 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENT L | 33.07 | 23.13 | 4.26 | 253.43 | 23.12 | 40.00 |
| AMRUTAJAN HEALTH LTD | 558.20 | 25.02 | 4.35 | 1613.79 | 490.00 | 789.95 |
| ASTRAZENECA PHARMA INDIA LTD. | 8604.25 | 103.40 | 26.92 | 21510.63 | 7630.00 | 10653.05 |
| BLISS GVS PHARMA LTD. | 300.20 | 32.28 | 2.74 | 3175.78 | 118.35 | 304.30 |
Choose a Plan That Suits Your Goals and Needs
Freedom Pack
Subscription Charge : FREE
Professional Pack
Subscription Fee : ₹2,500 Yearly
Signature
Account Opening : FREE
*Note: The Freedom Pack is free for the first year and has an annual fee of ₹431 from the second year onwards.
Beta Drugs Limited was incorporated as a private limited company with the name 'Beta Drugs Private limited' at Himachal Pradesh on September 21, 2005. Subsequently, the company was converted in to public limited company and the name of the company was changed to 'Beta Drugs Limited' on August 11, 2017
Beta Drugs is a part of Adley Group. Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India. The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers. The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014.
The company is primarily engaged in the manufacturing of oncology products. The Company's products range from anti-cancer tablets, capsules, injections and lyophilized injections. The Company started production of oncology products by manufacturing portfolio of over 35 products which is used for the treatment of various cancer disease.
The Company set up the first Oncology Unit in Adley Formulations Pvt Ltd. in 2008. It set up a new 'state of the art' manufacturing facility for oncology formulations in 2014; developed in-house Albumin bound Paclitaxel in 2015; started in-house API Plant - Adley Labs in 2017.
In October, 2017, the Company came up with a Public Issue of 22,96,000 Equity Shares by raising equity capital aggregating Rs 19.5 Crores.
The Company set up an Oncology Plant in Uzbekistan in 2018. In 2020, the Company launched GEM-RTU, ADLEAP, ADLANTE, BEXINIB; launched 1st Indian Brand of Dasatinib, BEEDAN. In 2025, the Company launched 1st Indian brand of Sunitinib, ADSUNIB.
Beta Drugs Ltd share price is for NSE ₹ 1,350.70 & for BSE ₹ 0.00 as on May 22 2026 03:29 PM.
The market cap of Beta Drugs Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on May 22 2026 03:29 PM.
The 52 Week High and Low of Beta Drugs Ltd for NSE is ₹ 2,000.00 and ₹ 990.10 and for BSE is ₹ 0.00 and ₹ 0.00.
The 1 year returns on the stock has been -22.21%.
As on May 22 2026 03:29 PM the price-to-earnings (PE) ratio for Beta Drugs Ltd share is 97.36.
As on May 22 2026 03:29 PM, the price-to-book (PB) ratio for Beta Drugs Ltd share is 147.53.
You can trade in Beta Drugs Ltd shares with Bajaj Broking by opening a demat account.
To buy Beta Drugs Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Beta Drugs Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found